MOUNTAINSIDE, N.J. -- September 01, 2026 -- Yorkville America Equities, LLC launched the Yorkville America MANGOS Plus Index ETF, trading under ticker FRUT on NYSE Arca and NYSE Texas, the firm announced Aug. 31, 2026. The fund combines six AI platform companies with seven hardware and infrastructure suppliers inside a single rules-based index, charging a 0.50% expense ratio with quarterly distributions. Tidal Investments, LLC serves as sub-adviser, and PINE Distributors LLC acts as distributor.

ARLINGTON, VA. -- September 01, 2026 -- Corvex, Inc. (Nasdaq: MOVE) said it will lift critical IT power capacity fivefold, from roughly 1.5 megawatts to approximately 8 megawatts by year-end 2026, backed by a $33 million private placement led by Goldman Sachs & Co. LLC, Morgan Stanley and Oppenheimer & Co. The Arlington, Virginia-based AI infrastructure provider is doubling its existing Mid-Atlantic data center and standing up a second facility in the Midwest, with both sites expected ready for service in the fourth quarter of 2026.

CARY, N.C. -- September 01, 2026 -- Veloxis Pharmaceuticals dosed the first participant on Aug. 31, 2026, in its Phase 2 RENGEVITY-201 trial testing pegrizeprument, an investigational immunosuppressive drug, against tacrolimus in kidney transplant recipients. The Cary, North Carolina-based company, a unit of Asahi Kasei Corporation, will enroll up to 120 de novo kidney transplant patients across multiple sites in the randomized, partially blinded study registered as NCT07290777.

Boise, Idaho -- September 01, 2026 -- Perpetua Resources Corp. (Nasdaq: PPTA; TSX: PPTA) said dual autoclaves for its Stibnite Gold Project in central Idaho are now being fabricated at a custom facility in Europe, one of several construction milestones the company detailed on August 31, 2026. Four drill rigs have completed roughly 5,800 meters of a 10,000-meter 2026 exploration program that has returned high-grade gold, antimony and tungsten intercepts. The update follows an August 18, 2026 ruling by the U.S.

INDIANAPOLIS and CAMBRIDGE, Mass. -- Aug. 31, 2026 -- Eli Lilly and Company agreed to pay up to $2.875 billion in cash to acquire Merida Biosciences, a Cambridge, Massachusetts-based biotechnology company developing antibody-degrading therapies for autoimmune and allergic diseases. The figure includes an upfront payment plus contingent milestone payments under a definitive agreement announced by both companies. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the fourth quarter of 2026.

NEW YORK -- September 01, 2026 -- Oppenheimer & Co. Inc. hired Joel Berry II as a Financial Advisor to its Robinson Private Client Group in Winston-Salem, North Carolina, the firm announced on Aug. 31, 2026. Berry arrives from Truist Financial to expand the team's advisory work with current and former athletes navigating Name, Image and Likeness deals and revenue-sharing arrangements. The Robinson Private Client Group, led by Managing Director Tanner G. Robinson, oversaw more than $6 billion in client assets as of June 30, 2026.

SOUTH SAN FRANCISCO, Calif. -- September 01, 2026 -- IDEAYA Biosciences said its FDA Type C meeting on IDE849, a DLL3-targeting antibody drug conjugate, produced agreement on a Phase 3 registrational trial design for extensive stage small cell lung cancer (ES-SCLC). The Nasdaq-listed company (IDYA) plans to enroll roughly 400 patients who have already received tarlatamab, randomizing them 1:1 between IDE849 monotherapy and an investigator's choice control arm of topotecan and amrubicin. IDEAYA is targeting trial initiation by year-end 2026.

Vancouver, BC -- September 01, 2026 -- Nevada Organic Phosphate Inc. (CSE: NOP, OTCQB: NOPFF) reported that drill hole MM26-10 at its Murdock Mountain project in northeast Nevada returned 10.89% P2O5 over 3.60 metres, with heavy metal contaminant levels far below the thresholds required for organic fertilizer certification. The hole marked a 1.5-kilometre step-out along strike from intercepts the company disclosed Aug. 26, 2026.

SUWANEE, Ga. -- September 01, 2026 -- YFORE Technology unveiled an expanded ultra-wideband (UWB) radar sensor portfolio at its Suwanee, Georgia facility on August 31, 2026. The automotive Tier 1 supplier said the system achieves a life-detection rate above 99% for in-cabin monitoring, with signal leakage through windows kept below 20 cm. YFORE positioned the technology across four vehicle functions: cabin safety, vehicle access, perimeter security and automated parking, built on proprietary high-precision algorithms rather than optical line-of-sight sensors.

SUWANEE, Georgia -- September 01, 2026 -- Tier-1 automotive supplier YFORE Technology has officially opened its manufacturing plant in Suwanee, Georgia, to produce anti-pinch sensor systems for North American automakers. The facility allows YFORE to supply automotive-grade closing sensor systems directly to regional OEMs under nearshore manufacturing, meeting local safety standards. The company said the sensors are already market-proven and now enter serial production at the new site.